or Try an Advanced Search...

    Blood Clots Stocks List

    Symbol Grade Name % Change
    NARI A Inari Medical, Inc. 0.70
    LMAT B LeMaitre Vascular, Inc. 7.34
    HAE F Haemonetics Corporation 0.45
    View As Page of Charts
    Related Industries: Medical Devices Medical Instruments & Supplies
    Related Stock Lists: Medicine Catheter Embolectomy Hematology Vascular Surgery Veins Angiology Artery Blood Blood Donation Blood Plasma Blood Transfusion Bypass Cardiovascular System Closure Systems Deep Vein Thrombosis Dialysis Disease FDA Filtration Products

    Related ETFs - A few ETFs which own one or more of the above listed Blood Clots stocks.

    Symbol Grade Name Weight
    XHE B SPDR S&P Health Care Equipment 5.08
    TMFS A Motley Fool Small-Cap Growth ETF 3.31
    PSCH C PowerShares S&P SmallCap Health Care Portfolio 2.71
    RNSC C First Trust Small Cap US Equity Select ETF 2.64
    NBSM C Neuberger Berman Small-Mid Cap ETF 2.39
    View all Blood Clots ETFs...
    Compare ETFs
    Compare PSCH to RNSC Compare TMFS to PSCH Compare XHE to RNSC

        Blood Clots Stocks Recent News

        Date Stock Title
        Nov 1 LMAT LeMaitre to Participate at Upcoming Investor Conferences in November
        Nov 1 LMAT LeMaitre Vascular Inc (LMAT) Q3 2024 Earnings Call Highlights: Robust Sales Growth and ...
        Oct 31 LMAT LeMaitre Vascular, Inc. (LMAT) Q3 2024 Earnings Call Transcript
        Oct 31 LMAT LeMaitre Vascular (LMAT) Surpasses Q3 Earnings and Revenue Estimates
        Oct 31 LMAT LeMaitre: Q3 Earnings Snapshot
        Oct 31 LMAT LeMaitre Vascular GAAP EPS of $0.49 beats by $0.06, revenue of $54.82M beats by $1.31M
        Oct 31 LMAT LeMaitre Q3 2024 Financial Results
        Oct 31 HAE Haemonetics (HAE) Earnings Expected to Grow: Should You Buy?
        Oct 31 NARI Edwards, Medtronic and Inari share trial data at TCT conference
        Oct 30 LMAT LeMaitre Vascular Q3 2024 Earnings Preview
        Oct 30 NARI Inari Medical Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
        Oct 29 NARI Inari Medical Inc (NARI) Q3 2024 Earnings Call Highlights: Record Revenue and Raised Guidance ...
        Oct 29 NARI PEERLESS Results Show Superiority of FlowTriever® Compared to Catheter-Directed Thrombolytics for Intermediate-Risk Pulmonary Embolism
        Oct 29 HAE Here's Why You Should Retain ABT Stock in Your Portfolio Now
        Oct 29 NARI Inari Medical Q3 Earnings Miss Estimates, Revenues Increase Y/Y
        Oct 29 NARI Key Takeaways From Inari Medical Analyst Ratings
        Oct 29 HAE Is GMED Stock a Smart Addition to Your Portfolio Right Now?
        Oct 29 NARI Inari Medical, Inc. (NARI) Q3 2024 Earnings Call Transcript
        Oct 28 NARI Inari Medical, Inc. (NARI) Reports Q3 Loss, Tops Revenue Estimates
        Oct 28 NARI Inari Medical GAAP EPS of -$0.31, revenue of $153M
        Related Industries: Medical Devices Medical Instruments & Supplies
        Related Stock Lists: Medicine Catheter Embolectomy Hematology Vascular Surgery Veins Angiology Artery Blood Blood Donation Blood Plasma Blood Transfusion Bypass Cardiovascular System Closure Systems Deep Vein Thrombosis Dialysis Disease FDA Filtration Products
        Blood Clots

        Blood clots are clumps of blood that form when components of the blood, such as proteins and platelets, become sticky and stick together. Blood clots can form in the veins, arteries, or heart and can be dangerous if they break off and travel to other parts of the body. Blood clots can cause blockages in the blood vessels, leading to stroke, heart attack, and other serious medical conditions.

        Browse All Tags